Biosynthesis of 5,15-dihydroxyeicosatetraenoic acid (5, 
Introduction
Oxygenation of arachidonic acid at the 5-carbon by 5-lipoxygenase (5-LOX) gives rise to 5S-hydroperoxyeicosatetraenoic acid (5S-HPETE). 5S-HPETE undergoes further transformation by 5-LOX to the leukotriene epoxide LTA 4 or reduction to the hydroxy derivative, 5S-HETE (1). 5-LOX is expressed in neutrophils, eosinophils, macrophages, and mast cells, and requires support by the accessory membrane protein 5-LOX activating protein (FLAP) for enzymatic activity in intact cells (2) . Whereas 5-LOX is the only enzyme capable of oxygenating the 5-position of arachidonic acid, several enzymes can oxygenate the 15-carbon (3): two 15-lipoxygenases, 15-LOX-1 (the 12/15-LOX in the mouse) (4) and 15-LOX-2 (5), COX-1 and COX-2, both forming 15-HETE and 11-HETE as by-products of prostaglandin biosynthesis (6, 7) , and aspirin-acetylated COX-2, a pure 15R-oxygenase (8) (9) (10) (11) .
Insertion of oxygen at one end of arachidonic acid does not impinge on the reactive pentadiene system at the other end, and, therefore, double oxygenation at both the 5-and 15-carbons of arachidonic acid is readily achievable. For example, formation of 5,15-diHETE in rat mononuclear cells and in human leukocytes is catalyzed by consecutive transformation of arachidonic acid by 5-LOX and 15-LOX in either order (12) .
Consecutive oxygenation of arachidonic acid by 5-LOX and 15-LOX is also instrumental in the biosynthesis of lipoxins. Lipoxin formation, however, additionally requires that one 4 2 catalysis as the second step. The main product of the reaction is a di-endoperoxide that is structurally similar to the arachidonic acid-derived endoperoxide of prostaglandin biosynthesis (17) . The catalytic by-products include 5,15-diHETE (as a ≈4:1 mixture of the 5S,15S-and 5S,15R-diastereomers) and 5S,11R-diHETE (16) . The diHETEs are the 5S-hydroxy analogues of the 15-and 11-HETE by-products of the COX-1 and COX-2 reactions with arachidonic acid (18, 19) .
Thus, 5,15-diHETE may be biosynthesized through a multitude of pathways that involve reactions of 5-LOX, 15-LOX, COX-1 and COX-2, or acetylated COX-2 as illustrated in Fig. 1 . Here, we analyzed the biosynthesis of 5,15-diHETE and 5,11-diHETE in activated human leukocytes. The enzymatic reactions involved were elucidated by the use of inhibitors of 5-LOX and COX-2 activities, deuterated HETE substrates, and stereochemical analysis of the diHETE products.
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Experimental Procedures
Materials
Arachidonic acid was purchased from NuChek Prep. d 8 (20) . 5-HETE was resolved into enantiomers using chiral-phase HPLC (21) . of d 8 -5-HETE could not be resolved into the enantiomers on the columns available (Chiralpak AD, Chiralpak AD-RH) and was used as the racemic mixture. [5, 6, 8, 9, 11, 12, 14, 15] -d 8 -15S-HETE was prepared using soybean LOX and reduction of the hydroperoxide with triphenylphosphine (22) . 6E,8Z,10E-5S,12S-diHETE was prepared by reaction of 5S-HETE with recombinant platelet 12-LOX expressed in the baculovirus/Sf9 insect cell system.
Leukocyte preparation and extraction
Leukocytes were isolated from peripheral blood from healthy human subjects. The study was approved by the Vanderbilt University Medical Center Institutional Review Board (protocol #091243). Venous blood (45 ml) was collected into a syringe containing 5 ml of citric acid and 10 ml of 6% dextran (250 kD average molecular weight). The blood was allowed to settle for 1 h, and the top layer was collected and centrifuged. The pellet was washed with PBS, and remaining red cells were lysed by treatment with a 10-fold excess of de-ionized water for 30 s. The leukocytes were centrifuged, washed, and diluted in PBS + containing 5 mM glucose to a concentration of 1.5 x 10 7 cells/ml. 1.0 x 10 7 cells were diluted to 1 ml, LPS (10 µg/ml) was added, and the cells were incubated at 37°C for 6 h. After addition of calcium ionophore A23187 (5 µM) the cells were incubated for an additional 15 min before addition of 10 ng of d 4 -LTB 4 standard, acidification to pH 4 using acetic acid, and extraction (Waters HLB cartridge). Products were eluted from the HLB cartridge with methanol, evaporated under a stream of nitrogen, and dissolved in 10 µl acetonitrile and 40 µl of LC-MS column solvent A.
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Leukocyte treatment
The inhibitors NS-398 (10 µM), AA-861 (10 µM), or MK-886 (5 µM) were added to the cells 30 min before the end of LPS-treatment. Aspirin was added at 2 mM final concentration (11) . The deuterated substrates, d 8 -5S -HETE and d 8 -15S-HETE, respectively, were added at 50, 100, and 500 ng/10 6 cells (0.75, 1.5, and 7.5 µM , respectively) at the time of addition of A23187 and incubated for 15 min before acidification and extraction.
Resolution of 5,15-diHETE diastereomers
Resolution of the 5S,15S-and 5S,15R-diHETE diastereomers was achieved after derivatization to the pentafluorobenzyl (PFB) esters using a Chiralpak AD-RH column 
LC-MS and NMR analysis
Samples were analyzed using a ThermoFinnigan Quantum Access triple quadrupole mass spectrometer equipped with an electrospray interface and operated in the negative ion mode. Instrument specific parameters (sheath and auxiliary gas pressures, temperature, and interface voltage) were optimized using direct infusion of a solution of PGE 2 NMR spectra were recorded on a Bruker AV-II 600 MHz spectrometer equipped with a cryoprobe. CDCl 3 was used as solvent (δ 7.25 ppm).
Results
Formation of diHETEs in activated leukocytes
RP-HPLC analysis of human leukocytes activated with LPS for 6 h followed by A23187
for 15 min showed formation of five products (I -V) with retention times and UV spectra that were characteristic of diHETE derivatives of arachidonic acid ( Fig. 2A) .
Products I and IV were identified as 5,15-diHETE and 5,11-diHETE, respectively, by comparison of HPLC retention times and UV spectra with authentic standards (Fig. 2B) prepared by reaction of recombinant COX-2 with 5S-HETE (16) . Product III was identified as LTB 4 by co-elution with an authentic standard and UV analysis (Fig. 2C, D) .
Product II was tentatively identified as 6E,8E,10E,14Z-5S,12R,S-diHETE (i.e., a mixture of 6-trans-LTB 4 and 6-trans-12-epi-LTB 4 ) based on retention time relative to LTB 4 and UV spectrum ( Fig 
Analysis of 5,15-diHETE and 5,11-diHETE formation
We hypothesized that 5,15-diHETE (I) and 5,11-diHETE (IV) are products of COX-2 catalyzed oxygenation of 5S-HETE in activated leukocytes ( 
Stereochemical analysis of 5,15-diHETE
The configuration of C-15 of 5,15-diHETE can give an indication to the enzymes involved in its biosynthesis (cf. (Fig. 5C ) showed that about 25% of total 5,15-diHETE was the 5S,15R-diastereomer.
Transformation of exogenous 5-HETE and 15-HETE to 5,15-diHETE
We analyzed the ability of activated leukocytes to utilize either (Fig. 6D ).
The levels of LTB 4 (which can not be formed from 5-HETE or 15-HETE) were reduced about 10-fold at the highest concentration of either of the exogenous HETEs added ( relative to the endogenous pathway. We found that exogenous 5-HETE was transformed to 5,15-diHETE, and inhibition by NS-398 proved that the transformation was catalyzed by COX-2. This confirmed that 5,15-diHETE in the activated leukocytes was, not to the least part, formed via route 1 in Fig. 1, i. e., by cross-over of the 5-LOX and COX-2 pathways.
Similar to previous studies (29, 38) , we found that addition of exogenous 15-HETE led to inhibition of the formation of LTB 4 (Fig. 6 ). This effect has initially been interpreted as an inhibitory effect of 15-HETE on 5-LOX activity (38) but was later found to be due to 1 ). This reaction is also a major pathway of biosynthesis of lipoxins (13, 14) .
The transformations of arachidonic acid in activated leukocytes analyzed in this study are summarized in Fig. 7 . 12-epi-6-trans-LTB 4 
15-LOX
5S,15S-diHETE (I) 5S,6R-& 5S,6S-diHETE (not detected)
by guest, on June 16, 2017 www.jlr.org Downloaded from
